Setshaba Research Centre
Soshanguve, South Africa
Research institute in Soshanguve
2088 Block H, Soshanguve - H, Soshanguve, 0152
About Setshaba Research Centre
"A well established and experienced community based, non-profit, medical research centre that conducts relevant, ethical and beneficial research, across a broad spectrum of diseases, including HIV and TB."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Vaccines & Prevention B.V.
5
FHI 360
2
Global Alliance for TB Drug Development
2
HIV Vaccine Trials Network
2
Hoffmann-La Roche
2
National Institute of Allergy and Infectious Diseases (NIAID)
2
Pfizer
2
Statens Serum Institut
2
Wits Health Consortium (Pty) Ltd
2
CONRAD
1
COVID-19 Prevention Network
1
Clinical Trials at Setshaba Research Centre
During the past decade, Setshaba Research Centre conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 6 clinical trials were completed, i.e. on
average, 21.4% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 4 clinical trials were completed. i.e. 22.2%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women
2009-05-01
2013-01-01
Completed
2,120
Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection
2011-10-01
2014-08-01
Completed
2,059
A Trial in Subjects Suspected to Have Tuberculosis, Comparing the Diagnostic Performance of C-Tb to QuantiFERON®, in Combination With a Safety Assessment of C-Tb Versus Tuberculin PPD RT23 SSI
2012-09-01
2014-09-01
Completed
1,190
Study to Identify Factors Influencing Access of Pregnant Women and Their Infants to Local Healthcare Systems
2012-11-01
2015-01-01
Completed
3,243
Safety Study Investigating if Concomitant Injections of C-Tb and 2 T.U Tuberculin Affect Induration Responses
2013-10-01
2014-09-01
Completed
456
The Evidence for Contraceptive Options and HIV Outcomes Trial
2015-12-14
2018-10-31
Completed
7,830
Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected Adults
2016-12-07
2020-02-12
Completed
334
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Setshaba Research Centre" #1 sponsor was "Janssen Vaccines & Prevention B.V." with 5 trials, followed by "FHI 360" with 2 trials
sponsored, "Global Alliance for TB Drug Development" with 2 trials sponsored, "HIV Vaccine Trials Network" with 2 trials sponsored and "Hoffmann-La Roche"
with 2 trials sponsored. Other sponsors include 15 different institutions and
companies that sponsored additional 21 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Setshaba Research Centre"
#1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials as a collaborator, "Setshaba Research Centre" with 3 trials as a collaborator, "Bill and Melinda Gates Foundation" with 2 trials as a collaborator, "Bio Analytical Research Corporation" with 2 trials as a collaborator and "BioVac" with 2 trials as a collaborator. Other collaborators include 41 different institutions and companies that were
collaborators in the rest 41 trials.
Clinical Trials Conditions at Setshaba Research Centre
According to Clinical.Site data, the most researched conditions in "Setshaba Research Centre" are
"HIV Infections" (5 trials), "Tuberculosis" (5 trials), "COVID-19" (4 trials), "SARS-CoV-2" (3 trials) and "HIV Prevention" (2 trials). Many other conditions were trialed in "Setshaba Research Centre" in a lesser frequency.
Clinical Trials Intervention Types at Setshaba Research Centre
Most popular intervention types in "Setshaba Research Centre" are "Biological" (17 trials), "Drug" (12 trials), "Other" (5 trials) and "Behavioral" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Ad26.COV2.S" (3 trials), "Baloxavir Marboxil" (2 trials), "C-Tb" (2 trials) and "Moxifloxacin" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Setshaba Research Centre
The vast majority of trials in "Setshaba Research Centre" are
24 trials for "All" genders and 9 trials for "Female" genders.
Clinical Trials Status at Setshaba Research Centre
Currently, there are NaN active trials in "Setshaba Research Centre".
1 are not yet recruiting,
9 are recruiting,
8 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 14 completed trials in Setshaba Research Centre,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Setshaba Research Centre, 4 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 19 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".